ClinicaliQ Trial Snapshot
- Enlighten Study: The EV-ICD Post Approval Registry — Active Not Recruiting • NCT06048731.
- Post-market study tracking safety and effectiveness of Medtronic's subcutaneous implantable defibrillator in routine NHS practice.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices. Conditions: Ventricular Arrhythmia, Tachycardia Interventions: Defibrillation using EV-ICD Lead Sponsor: Medtronic Planned Enrollment: 1000 participants